Martin Charles Faulkes - Sep 21, 2021 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role
Director
Signature
/s/ Martin Charles Faulkes
Stock symbol
VNRX
Transactions as of
Sep 21, 2021
Transactions value $
$0
Form type
4
Date filed
9/23/2021, 04:43 PM
Previous filing
Jul 16, 2021
Next filing
Nov 5, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VNRX Option (Right to Buy) Disposed to Issuer $0 -66.5K -100% $0.00* 0 Dec 16, 2019 Common Stock 66.5K $5.00 Direct F1
transaction VNRX Option (Right to Buy) Award $0 +66.5K $0.00 66.5K Sep 21, 2021 Common Stock 66.5K $5.00 Direct F1
transaction VNRX Option (Right to Buy) Disposed to Issuer $0 -70K -100% $0.00* 0 Apr 13, 2020 Common Stock 70K $3.60 Direct F2
transaction VNRX Option (Right to Buy) Award $0 +70K $0.00 70K Sep 21, 2021 Common Stock 70K $3.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transactions involved a cancellation and reissuance of outstanding options upon agreement of the reporting person. The "old" options were originally granted on December 16, 2019, vested in full on the date of grant, and were exercisable until March 30, 2023. The "replacement" options are fully-vested on the date of grant and have an expiration date of March 30, 2027.
F2 The reported transactions involved a cancellation and reissuance of outstanding options upon agreement of the reporting person. The "old" options were originally granted on April 13, 2020 and vested in full at 12 months from the date of grant, and were exercisable until April 13, 2026. The "replacement" options are fully-vested on the date of grant and have an expiration date of April 13, 2030.